|
NDC00026-0684-71
|
Talecris Biotherapeutics Holdings
|
Quote
|
|
ALBUMINAR-25
|
Armour Pharmaceutical Co
|
Quote
|
|
PLASBUMIN-25
|
Cutter Laboratories Inc
|
Quote
|
|
NDC000026-0684-71
|
Bayer Pharmaceuticals Corporation
|
Quote
|
|
NDC00053-7680-03
|
Armour Pharmaceutical Co
|
Quote
|
|
NDC00161-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00192-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00026-0684-71
|
Talecris Biotherapeutics Holdings
|
Quote
|
|
ALBUMINAR-25
|
Armour Pharmaceutical Co
|
Quote
|
|
PLASBUMIN-25
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00053-7680-03
|
Armour Pharmaceutical Co
|
Quote
|
|
NDC00161-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC000026-0684-71
|
Bayer Pharmaceuticals Corporation
|
Quote
|
|
NDC00192-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00026-0684-71
|
Talecris Biotherapeutics Holdings
|
Quote
|
|
ALBUMINAR-25
|
Armour Pharmaceutical Co
|
Quote
|
|
PLASBUMIN-25
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00161-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00053-7680-03
|
Armour Pharmaceutical Co
|
Quote
|
|
NDC000026-0684-71
|
Bayer Pharmaceuticals Corporation
|
Quote
|
|
NDC00192-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00026-0684-71
|
Talecris Biotherapeutics Holdings
|
Quote
|
|
ALBUMINAR-25
|
Armour Pharmaceutical Co
|
Quote
|
|
PLASBUMIN-25
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00053-7680-03
|
Armour Pharmaceutical Co
|
Quote
|
|
NDC00161-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC000026-0684-71
|
Bayer Pharmaceuticals Corporation
|
Quote
|
|
NDC00192-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00026-0684-71
|
Talecris Biotherapeutics Holdings
|
Quote
|
|
ALBUMINAR-25
|
Armour Pharmaceutical Co
|
Quote
|
|
PLASBUMIN-25
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00053-7680-03
|
Armour Pharmaceutical Co
|
Quote
|
|
NDC00161-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC000026-0684-71
|
Bayer Pharmaceuticals Corporation
|
Quote
|
|
NDC00192-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00026-0684-71
|
Talecris Biotherapeutics Holdings
|
Quote
|
|
ALBUMINAR-25
|
Armour Pharmaceutical Co
|
Quote
|
|
PLASBUMIN-25
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00053-7680-03
|
Armour Pharmaceutical Co
|
Quote
|
|
NDC00161-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC000026-0684-71
|
Bayer Pharmaceuticals Corporation
|
Quote
|
|
NDC00192-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00026-0684-71
|
Talecris Biotherapeutics Holdings
|
Quote
|
|
ALBUMINAR-25
|
Armour Pharmaceutical Co
|
Quote
|
|
PLASBUMIN-25
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00053-7680-03
|
Armour Pharmaceutical Co
|
Quote
|
|
NDC00161-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC00192-0684-71
|
Cutter Laboratories Inc
|
Quote
|
|
NDC000026-0684-71
|
Bayer Pharmaceuticals Corporation
|
Quote
|
